Key stats
About AIDA PHARMA INC
AiDa Pharmaceuticals, Inc. engages in the development, production, and distribution of pharmaceutical products. It offers Etimicin Sulfate, an antibiotic, which treats respiratory infection, kidney and urinogenital infection, soft skin tissue infection, and trauma and operations preventive uses. The company was founded on December 18, 2002 and is headquartered in Hangzhou, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of AIDA is 0.0002 USD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange AIDA PHARMA INC stocks are traded under the ticker AIDA.
AIDA stock is 0% volatile and has beta coefficient of −0.12. Check out the list of the most volatile stocks — is AIDA PHARMA INC there?
No, AIDA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, AIDA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AIDA PHARMA INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AIDA PHARMA INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AIDA PHARMA INC stock shows the sell signal. See more of AIDA PHARMA INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.